Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $9.0 million.

  • cbdMD's Shares Outstanding (Weighted Average) rose 148239.44% to $9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 million, marking a year-over-year increase of 148239.44%. This contributed to the annual value of $54.9 million for FY2021, which is 2446.23% up from last year.
  • Per cbdMD's latest filing, its Shares Outstanding (Weighted Average) stood at $9.0 million for Q4 2025, which was up 148239.44% from $5.8 million recorded in Q2 2025.
  • Over the past 5 years, cbdMD's Shares Outstanding (Weighted Average) peaked at $59.3 million during Q2 2022, and registered a low of $370132.0 during Q1 2024.
  • Over the past 5 years, cbdMD's median Shares Outstanding (Weighted Average) value was $4.4 million (recorded in 2023), while the average stood at $22.9 million.
  • In the last 5 years, cbdMD's Shares Outstanding (Weighted Average) plummeted by 9772.22% in 2023 and then skyrocketed by 148239.44% in 2025.
  • Quarter analysis of 5 years shows cbdMD's Shares Outstanding (Weighted Average) stood at $57.8 million in 2021, then tumbled by 97.68% to $1.3 million in 2022, then skyrocketed by 120.76% to $3.0 million in 2023, then crashed by 80.78% to $569008.0 in 2024, then soared by 1482.39% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q4 2025, $5.8 million for Q2 2025, and $778410.0 during Q1 2025.